PUBLISHER: TechNavio | PRODUCT CODE: 1441004
PUBLISHER: TechNavio | PRODUCT CODE: 1441004
The programmable infusion pumps market is forecasted to grow by USD 819.24 mn during 2023-2028, accelerating at a CAGR of 8.52% during the forecast period. The report on the programmable infusion pumps market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of chronic diseases, rising number of new product launches, and growing demand for self-administered drug delivery in home-care settings.
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 7.84% |
CAGR | 8.52% |
Incremental Value | $819.24mn |
Technavio's programmable infusion pumps market is segmented as below:
By Type
By End-user
By Geographical Landscape
This study identifies the technological advances in global programmable infusion pumps market as one of the prime reasons driving the programmable infusion pumps market growth during the next few years. Also, growing number of acquisitions in global programmable infusion pumps market and growing internet connectivity in programmable infusion pumps will lead to sizable demand in the market.
The report on the programmable infusion pumps market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading programmable infusion pumps market vendors that include Ace medical, Avanos Medical Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., BPL MEDICAL TECHNOLOGIES Pvt. Ltd., Canafusion Technologies Inc., Chemyx Inc., Contec Medical Systems Co. Ltd., ERENLER MEDIKAL SAN. TIC. LTD. STI., Flowonix Medical Inc., Fresenius SE and Co. KGaA, Guangzhou Beaconn Medical Science Technology Co. Ltd., ICU Medical Inc., IRadimed Corp., Johnson and Johnson, Medtronic Plc, Moog Inc., Terumo Corp., and Ypsomed Holding AG. Also, the programmable infusion pumps market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: